Can we predict lung transplant outcomes? new study seeks answers
NCT ID NCT07356752
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows about 4,200 lung transplant recipients in France to understand why some people develop serious complications like chronic lung allograft dysfunction (CLAD). Researchers will collect routine health data, lung function tests, and blood samples to build a model that predicts how well a transplanted lung will work over time. The goal is to identify early warning signs so doctors can act sooner and personalize care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to better tools for doctors to predict and catch lung transplant problems early, potentially improving long-term survival.
What could go wrong
This is an observational study, not a treatment trial. It may not directly change patient care, and the prediction models might not work as well in real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC REJECTION OF LUNG TRANSPLANT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHP - site de Bichat
Paris, Paris 18, 75018, France
-
APHP - site de Cochin
Paris, Paris 14, 75014, France
-
CHU Bordeaux & INSERM U1045
Talence, Talence, 33404, France
-
CHU LYON
Lyon, 69007, France
-
CHU Nantes Hôpital Maison Blanche
Nantes, 44000, France
-
CHU Strasbourg
Strasbourg, Strasbourg, 67084, France
-
CML La Fondation Hôpital Saint-Joseph
Le Plessis-Robinson, 92350, France
-
Chu Grenoble
Grenoble, 38700, France
-
Hôpital Foch
Suresnes, 92150, France